Furthermore, NT5C3A (50.00%), ANKMY1 (50.00%), and CD1C (50.00%) were the most frequent ANGs of CDH13 in patients with ACC (Table 2). This evidence concerns the gene CDH13 and adrenal cortex carcinoma.